SGIE Report 2026: Muslim-majority markets bolster local pharma manufacturing
The halal pharmaceutical sector is undergoing a structural shift in 2025/26, moving from a compliance-driven, import-reliant market into a capability-led, strategically positioned industry within a rapidly evolving global health order.
Muslims spent $112 billion on pharmaceutical products alone in 2024, rising 4.3% year-on-year, with a view to reach $146 billion by 2029, according to the State of the Global Islamic Economy 2025/26 Report.
Muslim markets bolstering local pharma manufacturing has been the sector’s overarching theme, expanding cross-border partnerships, and advancing traditional medicine toward mainstream, regulated integration. At the same time, demand is moving upmarket into specialty therapeutics such as oncology, as well as prevention and longevity.
Free, in under 30 seconds
Join thousands of professionals reading Salaam Gateway — the Global Islamic Economy Gateway.
Already a member? Sign in
- 5 free articles every month
- Weekly Islamic-economy newsletter
- Save articles to read later
Salaam Gateway